4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0001209191-07-008428
CIK 0000920465operating
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 6:46 PM ET
Size
9.4 KB
Accession
0001209191-07-008428
Insider Transaction Report
Form 4
TANSEY MICHAEL JAMES BYRON
Executive VP & CMO
Transactions
- Purchase
Common Stock
2007-02-05$3.11/sh+1,200$3,732→ 1,200 total - Purchase
Common Stock
2007-02-05$3.10/sh+700$2,170→ 1,900 total
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 6:46 PM ET
- Size
- 9.4 KB